Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederbusinesswire.com
Business Wire Health: Clinical Trials News
Get the latest updates from Business Wire Health: Clinical Trials News directly as they happen.
Follow now 104 followers
Latest posts
Last updated about 3 hours ago
Esco Aster Signs Exosome Clinical cGMP Manufacturing Contract With Shine-On Biomedical For A Novel First-In-Class HLA-G Targeting Exosome Drug Delivery Platform
about 3 hours ago
SINGAPORE--(BUSINESS WIRE)--Esco Aster, a vertically integrated cell and derivatives CRDMO based at...
GenSci and RTW Investments Announce Strategic Partnership on Anti-TSHR Antibody GS-098 (YB-101) for Graves’ Disease and Thyroid Eye Disease, With Global Ex-China Development Being Led by Yarrow Bioscience
about 5 hours ago
SHANGHAI & NEW YORK--(BUSINESS WIRE)--Shanghai Scizeng Medical Technology Co., LTD, a subsidiary...
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
about 7 hours ago
PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that as...
ENHERTU® (fam-trastuzumab deruxtecan-nxki) plus pertuzumab approved in the US as first new treatment in a decade for the 1st-line treatment of patients with HER2-positive metastatic breast cancer
about 7 hours ago
WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca and Daiichi Sankyo’s ENHERTU® (fam-trastuzumab deruxtecan-nxki) in combination with...
MindMed Announces New Employee Inducement Grant
about 7 hours ago
NEW YORK--(BUSINESS WIRE)--Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”)...
Verastem Oncology Announces Strategic Transition Plan to Accelerate Next Phase of Growth
about 7 hours ago
BOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new...
ENHERTU® Plus Pertuzumab Approved in the U.S. as First New Treatment in More Than a Decade for First-Line Treatment of Patients with HER2 Positive Metastatic Breast Cancer
about 9 hours ago
TOKYO & BASKING RIDGE, N.J.--(BUSINESS WIRE)--ENHERTU Plus Pertuzumab Approved in the U.S...
Cure Rare Disease Awarded $7.4 Million CIRM Grant to Advance Gene Therapy for Limb-Girdle Muscular Dystrophy Type 2i/R9
about 9 hours ago
WOODBRIDGE, Conn.--(BUSINESS WIRE)--Cure Rare Disease (CRD) announced it has been awarded a...
Studion and Viedoc Announce Strategic Partnership for eClinical Excellence
about 9 hours ago
BOSTON--(BUSINESS WIRE)--Studion and Viedoc Announce Strategic Partnership for eClinical Excellence.
Valcadia Healthcare Partners Advises CURC in its Acquisition by The START Center for Cancer Research
about 10 hours ago
DENVER--(BUSINESS WIRE)--Valcadia Healthcare Partners LLC (“Valcadia”) a leading healthcare investment banking and...
OrganaBio Expands to the San Francisco Bay Area with New PBMC Processing Laboratory in Hayward, California
about 12 hours ago
SAN FRANCISCO--(BUSINESS WIRE)-- #PBMC--OrganaBio opens up a new PBMC processing lab in...
Orca Bio Announces Orca-T® Phase 3 Data Published in Blood Demonstrate Significant Improvement in Survival Free from Chronic Graft versus Host Disease in Patients with Hematological Malignancies
about 14 hours ago
MENLO PARK, Calif.--(BUSINESS WIRE)--The results of the Precision-T Phase 3 study of...